Saltar al contenido
Merck
  • Efficacy of clindamycin hydrochloride capsules for the treatment of deep pyoderma due to Staphylococcus intermedius infection in dogs.

Efficacy of clindamycin hydrochloride capsules for the treatment of deep pyoderma due to Staphylococcus intermedius infection in dogs.

The Canadian veterinary journal = La revue veterinaire canadienne (1998-12-23)
D W Scott, K E Beningo, W H Miller, E Rothstein
RESUMEN

Clindamycin hydrochloride capsules (11 mg/kg body weight, q24 h) were administered orally to 20 dogs with deep staphylococcal pyoderma. Response to therapy was excellent in 100% of the dogs. Duration of therapy varied from 21 to 91 d, with an average duration of 45 d. Relapses occurred in 25% of the dogs within a 3-month period. One dog vomited when the clindamycin was given on an empty stomach. Under the conditions of the study, clindamycin was an effective, safe, and convenient antibiotic for the treatment of deep staphylococcal pyoderma in dogs.

MATERIALES
Referencia del producto
Marca
Descripción del producto

USP
Clindamycin hydrochloride, United States Pharmacopeia (USP) Reference Standard
USP
Clindamycin phosphate, United States Pharmacopeia (USP) Reference Standard